{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:41:30Z","timestamp":1762508490827,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jocn.2021.04.027","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T19:31:36Z","timestamp":1620329496000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation \u2013 K-PLUS registry"],"prefix":"10.1016","volume":"89","author":[{"given":"Makoto","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Inatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanosuke","family":"Kouzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Takita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniyasu","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Yonehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2021.04.027_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.03.014","article-title":"Prestroke anticoagulation and paroxysmal type are correlated with favorable outcome in ischemic stroke patients with atrial fibrillation","volume":"21","author":"Hoshino","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2021.04.027_b0010","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1161\/STROKEAHA.113.002523","article-title":"Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: The fukuoka stroke registry","volume":"44","author":"Nakamura","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2021.04.027_b0015","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jocn.2014.01.022","article-title":"Anticoagulation-related reduction of first-ever stroke severity in Chinese patients with atrial fibrillation","volume":"21","author":"Wang","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2021.04.027_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11239-015-1303-6","article-title":"Effect of anticoagulation on cardioembolic stroke severity, outcomes and response to intravenous thrombolysis","volume":"42","author":"Ill\u00e1n-Gala","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jocn.2021.04.027_b0025","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/STROKEAHA.118.023959","article-title":"Disparities and temporal trends in the use of anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"50","author":"Sur","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2021.04.027_b0030","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2169\/internalmedicine.54.4948","article-title":"Clinical features of ischemic stroke during treatment with dabigatran: An association between decreased severity and a favorable prognosis","volume":"54","author":"Hayashi","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.jocn.2021.04.027_b0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.2017.1371","article-title":"Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation","volume":"317","author":"Xian","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2021.04.027_b0040","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1253\/circj.CJ-18-0561","article-title":"Anticoagulants, reperfusion therapy, and outcomes in ischemic stroke patients with non-valvular atrial fibrillation- a single-center, 6-year experience of 546 consecutive patients","volume":"82","author":"Suda","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jocn.2021.04.027_b0045","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.09.019","article-title":"Adequate adherence to direct oral anticoagulant is associated with reduced ischemic stroke severity in patients with atrial fibrillation","volume":"28","author":"Yamashiro","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2021.04.027_b0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/ene.14134","article-title":"Effect of NOACs on stroke severity compared to warfarin: a meta-analysis of randomized controlled trials","volume":"27","author":"Costello","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2021.04.027_b0055","doi-asserted-by":"crossref","first-page":"e0213379","DOI":"10.1371\/journal.pone.0213379","article-title":"Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin k antagonist oral anticoagulants - a systematic review","volume":"14","author":"Meinel","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocn.2021.04.027_b0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1747-4949.2011.00672.x","article-title":"Impact of anticoagulation before stroke on stroke severity and long-term survival","volume":"7","author":"Haeusler","year":"2012","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jocn.2021.04.027_b0065","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.03.011","article-title":"The impact of prior antithrombotic status on cerebral infarction in patients with atrial fibrillation","volume":"23","author":"Kim","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2021.04.027_b0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000445723","article-title":"Causes of ischemic stroke in patients with non-valvular atrial fibrillation","volume":"42","author":"Nakamura","year":"2016","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2021.04.027_b0075","first-page":"116","article-title":"Analysis of recurrent stroke volume between VKA (vitamin K antagonist) and three NOACs (non-vitamin K antagonist oral anticoagulants) under oral anticoagulant therapy","volume":"3","author":"Oguro","year":"2016","journal-title":"Int J Pharma Sci Res"},{"key":"10.1016\/j.jocn.2021.04.027_b0080","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/ene.13405","article-title":"The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation","volume":"24","author":"Sakamoto","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2021.04.027_b0085","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1253\/circj.CJ-17-1110","article-title":"Insufficient warfarin therapy is associated with higher severity of stroke than no anticoagulation in patients with atrial fibrillation and acute anterior-circulation stroke","volume":"82","author":"Sakamoto","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jocn.2021.04.027_b0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11239-018-1634-1","article-title":"Impact of pre-admission treatment with non-vitamin k oral anticoagulants on stroke severity in patients with acute ischemic stroke","volume":"45","author":"Hoyer","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jocn.2021.04.027_b0095","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.038","article-title":"The dose of direct oral anticoagulants and stroke severity in patients with acute ischemic stroke and nonvalvular atrial fibrillation","volume":"27","author":"Kato","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2021.04.027_b0100","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00415-019-09412-y","article-title":"Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists","volume":"266","author":"Auer","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2021.04.027_b0105","first-page":"309","article-title":"The natural history of transient ischaemic cerebro-vascular attacks","volume":"33","author":"Marshall","year":"1964","journal-title":"Q J Med"},{"key":"10.1016\/j.jocn.2021.04.027_b0110","doi-asserted-by":"crossref","unstructured":"A classification and outline of cerebrovascular diseases. Ii. Stroke. 1975;6:564-616.","DOI":"10.1161\/01.STR.6.5.564"},{"key":"10.1016\/j.jocn.2021.04.027_b0115","doi-asserted-by":"crossref","unstructured":"Special report from the national institute of neurological disorders and stroke. Classification of cerebrovascular diseases III. Stroke. 1990;21:637-676.","DOI":"10.1161\/01.STR.21.4.637"},{"key":"10.1016\/j.jocn.2021.04.027_b0120","doi-asserted-by":"crossref","unstructured":"Benavente O, Hart R, Koudstaal P, Laupacis A, McBride R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2000:CD001927.","DOI":"10.1002\/14651858.CD001927"},{"key":"10.1016\/j.jocn.2021.04.027_b0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.53.1.126","article-title":"Baseline nih stroke scale score strongly predicts outcome after stroke: A report of the Rrial of Org 10172 in Acute Stroke Treatment (TOAST)","volume":"53","author":"Adams","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.04.027_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/281496","article-title":"Cardioembolic but not other stroke subtypes predict mortality independent of stroke severity at presentation","volume":"2011","author":"Stead","year":"2011","journal-title":"Stroke Res Treat"},{"key":"10.1016\/j.jocn.2021.04.027_b0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ahj.2016.03.019","article-title":"Effect of apixaban on brain infarction and microbleeds: Averroes-mri assessment study","volume":"178","author":"O'Donnell","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jocn.2021.04.027_b0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2018.03.019","article-title":"Influence of vitamin D antagonists and direct oral anticoagulation on coronary artery disease: A cta analysis","volume":"260","author":"Plank","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jocn.2021.04.027_b0145","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.amjmed.2018.05.007","article-title":"Effectiveness and safety of anticoagulants in adults with non-valvular atrial fibrillation and concomitant coronary\/peripheral artery disease","volume":"131","author":"Lopes","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.jocn.2021.04.027_b0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/STROKEAHA.119.025554","article-title":"Risks of stroke and mortality in atrial fibrillation patients treated with rivaroxaban and warfarin","volume":"51","author":"Alberts","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2021.04.027_b0155","doi-asserted-by":"crossref","first-page":"104456","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104456","article-title":"Multicenter prospective analysis of stroke patients taking oral anticoagulants: The PASTA Registry - study design and characteristics","volume":"28","author":"Suda","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821001946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821001946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:25:48Z","timestamp":1760822748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821001946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"alternative-id":["S0967586821001946"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.04.027","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation \u2013 K-PLUS registry","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}